跳至主要内容
临床试验/ISRCTN55999335
ISRCTN55999335已完成不适用

A randomised placebo-controlled trial of the effect of hormone replacement therapy on dementia and cognitive function in post-menopausal wome

Medical Research Council (MRC) (UK)0 个研究点目标入组 14,240 人开始时间: 2000年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14,240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Age 50-69, female, post-menopausal, no contraindication to HRT.
  • For both components, in addition to the WISDOM trial inclusion criteria, subjects will only be recruited if they can be randomised to receive placebo, ie excluding the 21% of WISDOM recruits with a total hysterectomy who are already taking HRT.
  • For the dementia component sub-study only those who will reach the age of 65 years before the end of the projected follow-up period (2009) will be included.

排除标准

  • Not provided at time of registration

研究者

发起方
Medical Research Council (MRC) (UK)

相似试验